JP2022544718A - 敗血症性心筋症を治療するための組成物および方法 - Google Patents

敗血症性心筋症を治療するための組成物および方法 Download PDF

Info

Publication number
JP2022544718A
JP2022544718A JP2020540234A JP2020540234A JP2022544718A JP 2022544718 A JP2022544718 A JP 2022544718A JP 2020540234 A JP2020540234 A JP 2020540234A JP 2020540234 A JP2020540234 A JP 2020540234A JP 2022544718 A JP2022544718 A JP 2022544718A
Authority
JP
Japan
Prior art keywords
sdg
subject
sepsis
mitochondrial
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020540234A
Other languages
English (en)
Japanese (ja)
Inventor
クリストフィドウ－ソロミドウ，メルポ
Original Assignee
ユニヴァーシティー オヴ ペンシルバニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニヴァーシティー オヴ ペンシルバニア filed Critical ユニヴァーシティー オヴ ペンシルバニア
Publication of JP2022544718A publication Critical patent/JP2022544718A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020540234A 2017-09-27 2018-10-19 敗血症性心筋症を治療するための組成物および方法 Pending JP2022544718A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762564173P 2017-09-27 2017-09-27
PCT/US2018/053199 WO2019067771A1 (fr) 2017-09-27 2018-10-19 Compositions et procédés pour traiter la cardiomyopathie septique

Publications (1)

Publication Number Publication Date
JP2022544718A true JP2022544718A (ja) 2022-10-21

Family

ID=65903325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540234A Pending JP2022544718A (ja) 2017-09-27 2018-10-19 敗血症性心筋症を治療するための組成物および方法

Country Status (5)

Country Link
US (1) US20210128596A1 (fr)
EP (1) EP3703670A4 (fr)
JP (1) JP2022544718A (fr)
CA (1) CA3077036A1 (fr)
WO (1) WO2019067771A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3917508A4 (fr) 2019-01-28 2022-12-21 Mitochondria Emotion, Inc. Activateurs de la mitofusine et leurs procédés d'utilisation
AU2020215510A1 (en) 2019-01-28 2021-07-22 Mitochondria Emotion, Inc. Trans-4-hydroxycyclohexyl phenyl amide mitofusin activators and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201652C (fr) * 1996-04-04 2007-09-11 The University Of Saskatchewan Utilisation de sdg purifie comme antioxydant
US20060194878A1 (en) * 2002-10-07 2006-08-31 Lopaschuk Gary D Methods of cardioprotection using dichloroacetate in combination with an inotrope
CA2950744A1 (fr) * 2014-05-30 2015-12-03 The Trustees Of The University Of Pennsylvania Utilisation de secoisolariciresinol diglucosides (sdg) et composes associes pour la protection contre le rayonnement et les dommages chimiques

Also Published As

Publication number Publication date
WO2019067771A1 (fr) 2019-04-04
EP3703670A4 (fr) 2021-08-25
US20210128596A1 (en) 2021-05-06
CA3077036A1 (fr) 2019-04-04
EP3703670A1 (fr) 2020-09-09

Similar Documents

Publication Publication Date Title
US11690812B2 (en) Methods and compositions for the treatment of steatosis-associated disorders
Kokkinaki et al. Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy
PT2135603E (pt) Composições e métodos para aumentar a sensibilidade à insulina
US20210338603A1 (en) Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes
CN108697678A (zh) sGC刺激剂在非酒精性脂肪性肝炎（NASH）治疗中的应用
JP2018514555A (ja) 勃起機能不全を治療又は改善するための方法及びｓｇｌｔ２阻害薬を含む医薬組成物
US9649334B2 (en) Use of nitrite salts in chronic ischemia
JP2000505426A (ja) 神経細胞機能の維持、その消失の防止又は回復のためのデプレニル化合物の利用
Li et al. Direct cardiac actions of sodium-glucose cotransporter 2 inhibition improve mitochondrial function and attenuate oxidative stress in pressure overload-induced heart failure
BR112021006132A2 (pt) compostos bifenil sulfonamida para o tratamento de doenças de colágeno tipo iv
WO2014028042A1 (fr) Probénécide pour traiter une cardiomyopathie, un dysfonctionnement cardiaque systolique et les symptômes d'insuffisance cardiaque congestive
JP2022544718A (ja) 敗血症性心筋症を治療するための組成物および方法
EP3258930A1 (fr) Oxabicycloheptanes et oxabicycloheptènes permettant de traiter des troubles dépressifs et de stress
JP2002542284A (ja) テトラックの薬学組成物およびその使用方法
US20150079183A1 (en) Lercanidipine Hydrochloride and Losartan Potassium Compound Preparation and Preparation Method Thereof
US9943518B2 (en) Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, edema, and damage in a patient having muscle fatigue due to increased age or exercise
Anderson Management of beta-adrenergic blocker poisoning
JP2002536325A (ja) 疾患を治療するためのｌ−アルギニン基盤の処方およびその使用方法
US20220133702A1 (en) Cystic fibrosis transmembrane conductance regulator modulators for treating autosomal dominant polycystic kidney disease
CN110604735B (zh) 一种治疗肝纤维化、硬皮病的化合物及其应用
WO2024060359A1 (fr) Utilisation d'un composé glycérophospholipide dans la prévention et le traitement de l'hyperlipidémie, de l'athérosclérose, de la stéatose hépatique non alcoolique et de l'obésité
CN109364067B (zh) 一种化合物在制备提高血脑屏障通透性药物中的用途
KR20240099023A (ko) 나트륨 포도당 운반체-2 저해제 및 안지오텐신 ⅱ 수용체 차단제를 함유하는 심혈관 질환 예방 또는 치료용 약학적 조성물
US20170071925A1 (en) Ciclopirox for Use in Modulation of Glucose Homeostasis
Zhang et al. Irisin attenuates acute glaucoma-induced neuroinflammation by activating microglia-integrin αVβ5/AMPK and promoting autophagy

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20210121

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20210121

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210805